Home > Boards > US Listed > Biotechs > Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Receives Complete Response Letter from FDA

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
realfast95 Member Profile
Member Level 
Followed By 53
Posts 15,576
Boards Moderated 0
Alias Born 11/29/06
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/21/2021 4:34:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/21/2021 8:41:01 AM
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce U.S. Licensing and Supply Deal for Riluzole Oral Film fo... PR Newswire (US) - 1/21/2021 8:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 1/20/2021 6:05:35 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 1/8/2021 4:46:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 7:01:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2021 7:36:05 AM
Aquestive Therapeutics Provides Business Update GlobeNewswire Inc. - 1/7/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 4:06:10 PM
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences GlobeNewswire Inc. - 1/4/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 7:00:55 AM
Aquestive Therapeutics Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer GlobeNewswire Inc. - 12/16/2020 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 12/1/2020 6:01:05 AM
Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire Inc. - 11/25/2020 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2020 7:15:57 AM
Aquestive Therapeutics Receives First Milestone Payment from KYNMOBI™ Monetization GlobeNewswire Inc. - 11/23/2020 7:00:00 AM
Aquestive Therapeutics Completes FDA Type A Meeting on Libervant GlobeNewswire Inc. - 11/18/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2020 4:36:10 PM
Aquestive Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire Inc. - 11/4/2020 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/3/2020 7:03:47 AM
Aquestive Therapeutics Signs Royalty Monetization Agreement with Marathon Asset Management for up to $125 Million GlobeNewswire Inc. - 11/3/2020 7:00:00 AM
Aquestive Therapeutics to Announce Third Quarter Financial Results and Recent Business Highlights on November 4 and Host Conf... GlobeNewswire Inc. - 10/14/2020 7:30:10 AM
Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant™ (diazepam) Buccal Film for Management of S... GlobeNewswire Inc. - 9/25/2020 5:38:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2020 5:28:37 PM
Aquestive Therapeutics Initiates Phase 1 Pharmacokinetic Trial of AQST-108 (Sublingual Film Formulation Delivering Systemic ... GlobeNewswire Inc. - 8/20/2020 7:30:10 AM
realfast95 Member Level  Friday, 09/25/20 07:17:32 PM
Re: DorseyE post# 130
Post # of 143 
Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant™ (diazepam)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences